Skip to main content
logo
UnitedHealth Group Incorporated (UNH)
NYSE: UNH · Real-Time Price · USD
374.94
-2.89 (-0.76%)
At close: Sep 29, 2026, 4:00 PM EDT
374.80
-0.14 (-0.04%)
After-hours: Sep 29, 2026, 7:59 PM EDT

UnitedHealth Group Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Market Capitalization
336,544377,452245,608299,026312,729283,001479,081465,535539,904468,715456,081486,945467,034447,491440,854495,373472,406481,873479,830472,941368,436
Market Cap Growth (YoY)
8.00%33.38%-48.73%-35.77%-42.08%-39.62%5.04%-4.40%15.60%4.74%3.45%-1.70%-1.14%-7.13%-8.12%4.74%28.22%27.52%36.42%42.14%24.35%
Enterprise Value
381,287434,806311,835361,978373,386343,686545,495521,065598,591524,168508,252520,885500,613485,476488,517513,470507,492508,765513,450503,175401,127

Price Ratios

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
PE Ratio
24.1426.7320.3924.8017.7813.2921.6732.3237.7133.24-21.7621.5421.2021.2924.6224.3126.4027.5027.3623.88
PS Ratio
0.750.840.550.670.720.671.171.161.371.221.201.311.301.281.311.531.501.571.611.641.32
PB Ratio
3.453.562.332.942.962.704.564.545.174.724.714.924.974.864.875.745.705.946.186.184.94
P/FCF Ratio
14.2515.9812.4918.6018.0011.2019.2722.4841.2375.5343.37-17.6711.7212.89-15.0823.5624.9723.7816.09
P/OCF Ratio
12.4613.9710.6115.1814.929.7716.8019.2332.4448.8332.85-15.7110.8211.85-13.9120.9622.1621.1714.61

EV Ratios

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
EV/Sales Ratio
0.850.970.690.810.860.811.331.301.521.361.341.401.391.391.451.581.611.661.731.751.44
EV/EBITDA Ratio
14.2915.3212.1914.0612.199.8314.4914.3216.5214.5514.0414.3414.0914.1614.7416.1316.7617.8618.8018.5916.04
EV/EBIT Ratio
15.8218.0514.6716.9314.1711.1816.3016.1418.5916.3715.7816.1015.8615.9216.5218.0618.7420.0821.2320.9918.28
EV/FCF Ratio
16.1418.4115.8622.5221.4913.6021.9425.1745.7184.4648.33-18.9412.7114.28-16.2024.8826.7225.3017.52

Financial Efficiency

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Debt / Equity Ratio
0.690.690.740.820.760.760.770.750.750.760.760.630.670.710.780.670.590.630.610.600.63
Debt / EBITDA Ratio
2.592.031.944.813.703.182.002.182.002.112.061.801.661.811.951.831.471.621.531.821.80
Debt / FCF Ratio
3.113.113.965.164.613.133.273.715.9612.107.00-2.401.722.06-1.552.512.472.312.05
Net Debt / Equity Ratio
0.420.420.470.580.500.480.480.500.440.490.470.380.260.260.320.400.120.330.280.320.35
Net Debt / EBITDA Ratio
1.681.581.952.281.731.451.341.421.261.361.251.020.690.690.871.080.320.940.810.911.03
Net Debt / FCF Ratio
1.901.902.543.653.052.002.032.493.487.874.301.450.930.620.841.460.311.311.151.241.13
Quick Ratio
0.700.700.720.700.750.770.770.750.830.780.760.690.720.710.720.650.730.670.670.660.66
Current Ratio
0.780.780.800.790.820.850.850.830.910.850.820.750.770.760.770.730.780.730.740.730.72
Asset Turnover
1.441.441.461.451.441.441.351.381.391.431.361.311.321.391.361.371.421.481.391.37
Return on Equity (ROE)
21.47%25.05%0.84%9.66%13.61%24.93%22.35%24.58%18.03%-4.99%23.54%25.95%24.76%26.10%23.20%26.26%26.20%26.72%22.19%22.66%
Return on Assets (ROA)
6.42%7.22%2.24%3.46%4.16%7.50%6.50%7.44%6.90%7.11%6.92%7.58%7.14%7.64%7.05%7.88%7.90%8.02%6.51%6.75%
Return on Invested Capital (ROIC)
3.59%3.98%1.51%1.84%2.43%3.98%3.66%4.01%3.56%-5833.39%3.99%4.25%3.95%4.17%3.95%4.38%4.32%4.43%3.72%3.72%

Yields

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Earnings Yield
4.20%3.74%4.90%4.03%5.62%7.52%4.61%3.09%2.65%3.01%3.37%4.60%4.64%4.72%4.70%4.06%4.11%3.79%3.64%3.65%4.19%
FCF Yield
7.02%6.26%8.01%5.38%5.56%8.93%5.19%4.45%2.43%1.32%2.31%5.27%5.66%8.54%7.76%4.72%6.63%4.24%4.00%4.21%6.21%
Dividend Yield
2.48%2.17%3.31%2.70%2.56%2.82%1.67%1.69%1.43%1.60%1.61%1.47%1.49%1.52%1.50%1.30%1.33%1.27%1.24%1.22%1.51%
Payout Ratio
59.74%38.06%31.93%20020.00%85.26%58.72%30.39%34.86%31.99%45.90%-31.86%29.77%31.91%27.39%32.37%29.30%30.47%27.11%33.53%33.46%
Buyback Yield / Dilution
1.47%0.44%0.87%1.83%2.37%1.94%0.43%0.86%0.64%1.28%2.23%1.27%1.27%1.05%1.15%0.84%0.73%0.63%0.31%0.62%0.73%
Total Shareholder Return
3.94%2.61%4.18%4.53%4.93%4.76%2.10%2.55%2.07%2.88%3.83%2.74%2.76%2.57%2.65%2.14%2.06%1.89%1.55%1.84%2.24%
SEC Filings: 10-K · 10-Q